✦ LIBER ✦

A phase 2a study to investigate the effect of a single dose of migalastat HCl, a pharmacological chaperone, on agalsidase activity in subjects with Fabry disease

✍ Scribed by Warnock, David; Bichet, Daniel; Holida, Myrl; Goker-Alpan, Ozlem; Nicholls, Kathy; Thomas, Mark; Eyskens, Francois; Shankar, Suma; Dasouki, Majed; Johnson, Franklin; Boudes, Pol

Book ID: 122631278
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 96 KB
Volume: 108
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2012.11.262

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and pharmacodynamic effects of a

Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies

✍ Dominique P Germain, Roberto Giugliani, Derralynn A Hughes, Atul Mehta, Kathy Ni 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 307 KB

A novel probe drug interaction study to

A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV-positive subjects

✍ Anton L. Pozniak; Marta Boffito; Deborah Russell; Caroline E. Ridgway; Gary J. M 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB

A phase 2a study to investigate drug–dru

A phase 2a study to investigate drug–drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alfa-glucosidase in subjects with Pompe disease

✍ Kishnani, Priya; Tarnopolsky, Mark; Sivakumar, Kumarswamy; Roberts, Mark; Byrne, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A phase II safety and tolerability study

A phase II safety and tolerability study to investigate the effect of AZD5213 on sleep in subjects with mild cognitive impairment and mild Alzheimer's disease

✍ Hannesdottir, Kristin; Minkwitz, Margaret; Raudibaugh, Karen; Vis, Peter; Ackaer 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 161 KB

T.P.46 A novel phase 2a study design to

T.P.46 A novel phase 2a study design to investigate drug-drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alpha-glucosidase in subjects with Pompe disease

✍ Kishnani, P.; Tarnopolsky, M.; Sivakumar, K.; Byrne, B.; Goker-Alpan, O.; Guter, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 48 KB

P2-082: A randomised, single-blind, plac

P2-082: A randomised, single-blind, placebo-controlled, multicentre study to investigate the pharmacodynamic effects of lithium on GSK-3 activity in patients with mild Alzheimer’s disease

✍ Peter Annas; Johannes Schröder; Lutz Frölich; Matthias Riepe; Inga Kraft; Thomas 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 54 KB